ExpertiseUpdated on 18 March 2026
Antibody discovery expertise
About
**
LxBio AB** (part of Lxbio Pharmaceuticals) offer bespoken, end-to-end antibody discovery services, covering the whole antibody discovery life cycle:
- Antibody discovery using Single B Cell or Phage Display Technologies
- Antibody Engineering which covers affinity maturation services as well as antibody re-formatting
- Antibody Characterization, both functional and biophysical characterizations
- Antibody Production for R&D and pre-clinical studies
- Cell Line Development for stable AB production, using Single Cell Technology
We can operate either as a typical fee-for-service company or we can integrate in research consortia and apply for grant opportunities. We are an agile and very cost effective company looking for partners that want to fast-track their antibody development projects. We can work with multiple antibody formats.
Organisation
Similar opportunities
Project cooperation
Antibody inducing Immunotherapies
- Early
- Planning
- Healthcare
- EU projects
Arin Ghasparian
Co-founder & CEO at Shape Biopharmaceuticals
Au ZH, Switzerland
Expertise
CDMO End to End Services for Mammalian Cell Based Biologics
- Other
- Healthcare
- Biotech, Pharma and Cosmetics
Diksha Gupta
Head of Global Business Development and Marketing at Kemwell Biopharma
Bengaluru, India
Expertise
Connect with Biopharma Experts at the Bioproduction Forum 2026
- Healthcare
- Biotech, Pharma and Cosmetics
Pierre-Mehdi Hammoudi
Scientific Event Manager at MabDesign
Lyon, France